Advertisement

Topics

Synlogic Presents Preclinical Data from Synthetic Biotic Immuno-Oncology Program at the American Association for Cancer Research 2018 Annual Meeting

16:02 EDT 16 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
– Data highlight the application of Synthetic Biotic medicines for the potential treatment of a variety of solid tumors – – Company is advancing the first candidate from this program into IND-enabling studies in 2...

Other Sources for this Article

Synlogic
MEDIA CONTACT:
Courtney Heath
Phone: 617-872-2462
Email: courtney@scientpr.com
or
INVESTOR CONTACT:
Elizabeth Wolffe, Ph.D.
Phone: 617-207-5509
Email: liz@synlogictx.com

NEXT ARTICLE

More From BioPortfolio on "Synlogic Presents Preclinical Data from Synthetic Biotic Immuno-Oncology Program at the American Association for Cancer Research 2018 Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...